| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 1421372-66-8 | AZD9291DA |
≥98% | | 询价 |
| 2 | 1034916-72-7 | AZD-9164 bromide |
≥98% | | 询价 |
| 3 | 933785-68-3 | AZD8926 |
≥98% | | 询价 |
| 4 | 1648550-37-1 | Navafenterol(AZD-8871)saccharinate |
≥98% | | 询价 |
| 5 | 1435519-06-4 | Navafenterol(AZD8871) |
≥98% | | 询价 |
| 6 | 1598424-76-0 | BMS-466442 |
≥98% | | 询价 |
| 7 | 7681-93-8 | Natamycin |
≥98% | | 询价 |
| 8 | 1126366-36-6 | AZD8542 |
≥98% | | 询价 |
| 9 | 69004-03-1 | Toltrazuril |
≥98% | | 询价 |
| 10 | 1198309-73-7 | AZD-8418 |
≥98% | | 询价 |
| 11 | 569-77-7 | Purpurogallin |
≥98% | | 询价 |
| 12 | 390412-29-0 | Nafadotride |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | 1234-71-5 | Namoxyrate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 3426-01-5 | Phenopyrazone |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 15 | 101506-83-6 | Namirotene |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 1816331-66-4 | GSK864 |
| | 询价 |
| 17 | 1650550-25-6 | Enasidenib mesylate(AG-221 mesylate) |
| | 询价 |
| 18 | 1446502-11-9 | Enasidenib(AG-221) |
| | 询价 |
| 19 | 1803274-65-8 | BAY-1436032 |
| | 询价 |
| 20 | 1432660-47-3 | AGI-6780 |
| | 询价 |
| 21 | 1355326-35-0 | AGI-5198(IDH-C35) |
| | 询价 |
| 22 | 198474-05-4 | PF-06840003 |
| | 询价 |
| 23 | 122517-78-6 | Naltriben mesylate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | 1402837-78-8 | Navoximod(NLG-1488) |
| | 询价 |
| 25 | 1923833-60-6 | Linrodostat(BMS-986205 ONO-7701) |
| | 询价 |
| 26 | 110117-83-4 | Indoximod(NLG-81891-Methyl-D-tryptophan) |
| 500mg | 询价 |
| 27 | 914471-09-3 | IDO5L |
| | 询价 |
| 28 | 1888341-29-4 | IDO inhibitor 12 |
| | 询价 |
| 29 | 1402837-77-7 | IDO inhibitor 8(NLG-1487) |
| | 询价 |
| 30 | 1402836-58-1 | IDO inhibitor 7(NLG-919 analogueGDC-0919 analogue) |
| | 询价 |
| 31 | 1402837-76-6 | IDO inhibitor 6(NLG-1486) |
| | 询价 |
| 32 | 108383-95-5 | Naltiazem |
≥98% | | 询价 |
| 33 | 160359-68-2 | Naltalimide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 1629125-65-0 | IDO inhibitor 4 |
| | 询价 |
| 35 | 57-29-4 | Nalorphine HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 2070018-30-1 | IDO inhibitor 3 |
| | 询价 |
| 37 | 55096-26-9 | Nalmefene |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | 1668565-74-9 | IDO inhibitor 2 |
| | 询价 |
| 39 | 212141-51-0 | Vatalanib dihydrochloride |
| 10mg | 询价 |
| 40 | 589-09-3 | N-Allylaniline |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 914638-30-5 | IDO inhibitor 1 |
| | 询价 |
| 42 | 126844-81-3 | Nagstatin |
≥98% | | 询价 |
| 43 | 94825-74-8 | NAGKi |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 2239305-70-3 | IACS-8968(S-enantiomer)(IDO/TDO Inhibitor(S-enantiomer)) |
| | 询价 |
| 45 | 19891-51-1 | Nagilactone B |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | 2239305-67-8 | IACS-8968(R-enantiomer)(IDO/TDO Inhibitor(R-enantiomer)) |
| | 询价 |
| 47 | 2144425-14-7 | IACS-8968(IDO/TDO Inhibitor) |
| | 询价 |
| 48 | 1505-95-9 | Naftypramide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | 1204669-58-8 | Epacadostat(INCB 024360 IDO Inhibitor 1) |
| | 询价 |
| 50 | 28820-28-2 | Naftoxate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 6020-18-4 | Coptisine chloride |
| | 询价 |
| 52 | 3486-66-6 | Coptisine(Coptisin) |
| | 询价 |
| 53 | 77603-42-0 | 8-Nitrotryptanthrin |
| | 询价 |
| 54 | 15687-37-3 | Naftazone |
≥98% | | 询价 |
| 55 | 3200-06-4 | Nafronyl oxalate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 1149705-71-4 | XL888 |
| | 询价 |
| 57 | 38748-32-2 | Triptolide(PG490) |
| | 询价 |
| 58 | 867164-40-7 | TRC051384 |
| | 询价 |
| 59 | 1260533-36-5 | TAS-116 |
| | 询价 |
| 60 | 911710-03-7 | Tanespimycin Hydrochloride(17-AAG HydrochlorideNSC 330507 Hydrochloride) |
| | 询价 |
m.cnreagent.com